Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
🧐 ProPicks AI October update is out now! See which stocks made the list Pick Stocks with AI
Correvio Pharma Corp (CORV_old)
Add to/Remove from a Portfolio
Add to Watchlist
0.4199
0.0000
0.00%
Type:
Equity
Market:
United States
- Volume: 0
- Bid/Ask: 0.0000 / 0.0000
- Day's Range: 0.4160 - 0.4200
Correvio Pharma
0.4199
0.0000
0.00%
- General
- Chart
- News & Analysis
- Financials
- Technical
- Forum
- Financial Summary
- Income Statement
- Balance Sheet
- Cash Flow
- Ratios
- Dividends
- Earnings
CORV_old Financial Summary
A brief financial summary of Correvio Pharma Corp as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.
For the fiscal year ended 31 December 2019, Correvio Pharma Corp revenues increased 14% to $32.6M. Net loss increased from $16.6M to $35.2M. Revenues reflect Europe segment increase of 39% to $22.4M. Higher net loss reflects Gain on disposal of Canadian operations decrease from $18.5M (income) to $0K, Selling, general and administration increase of 9% to $46.3M (expense).
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter
CORV_old Income Statement
Gross margin TTM -
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -
Total Revenue Net Income
| Period Ending: | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|
| Total Revenue | 11.32 | 6.67 | 7.39 | 7.25 |
| Gross Profit | 8.43 | 4.39 | 4.98 | 5.01 |
| Operating Income | -3.9 | -7.78 | -8.62 | -7.17 |
| Net Income | -4.94 | -10.78 | -10.47 | -9 |
CORV_old Balance Sheet
Quick Ratio MRQ -
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
Total Assets Total Liabilities
| Period Ending: | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|
| Total Assets | 58.89 | 59.37 | 58.75 | 63.31 |
| Total Liabilities | 59.73 | 57.83 | 58.97 | 57.18 |
| Total Equity | -0.83 | 1.54 | -0.22 | 6.12 |
CORV_old Cash Flow Statement
Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow -90.84%
Cash Net Change in Cash
| Period Ending: | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|
| Period Length: | 12 Months | 9 Months | 6 Months | 3 Months |
| Cash From Operating Activities | -27.07 | -21.17 | -13.76 | -7.61 |
| Cash From Investing Activities | 0.21 | 0.23 | 0.27 | 0.11 |
| Cash From Financing Activities | 24.64 | 23.33 | 10.79 | 7.94 |
| Net Change in Cash | -2.33 | 2.1 | -2.72 | 0.33 |
* In Millions of (except for per share items)
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Write your thoughts about Correvio Pharma Corp
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review